Publicacións nas que colabora con Ana Echarri Piudo (7)

2024

  1. Long-Term Evaluation of Intensified Ustekinumab in Crohn's Disease: Real-Life Results

    JOURNAL OF CROHNS & COLITIS, Vol. 18, Núm. Supl 1, pp. I1039

2023

  1. Preoperative optimization of patients with inflammatory bowel disease: a multicentre study of EIGA Group

    JOURNAL OF CROHNS & COLITIS, Vol. 17, Núm. Supl 1, pp. I356

2022

  1. TELEIBD: A telematic fast-track pathway for patients with high suspicion of Inflammatory Bowel Disease in primary care

    JOURNAL OF CROHNS & COLITIS, Vol. 16, Núm. Supl 1, pp. I314-I315

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Letter: double‐dose intensification – a quick way to reverse antibody formation and loss of response in patients treated with adalimumab

    Alimentary Pharmacology & Therapeutics, Vol. 49, Núm. 6, pp. 821-822

2010

  1. Experiencia con la infusión continua de levodopa intraduodenal (Duodopa®) en pacientes con enfermedad de Parkinson avanzada en un hospital de segundo nivel asistencial

    Neurologia, Vol. 25, Núm. 9, pp. 536-543

2009

  1. P2.158 Duodenal levodopa infusion improves motor symptoms and quality of life in advanced Parkinson disease: report of nine patients

    Parkinsonism & Related Disorders, Vol. 15, pp. S132